Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1050 Results

Title
Intervention Indication Therapeutic Area Year Actions
Brigatinib (Alunbrig) for anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer Brigatinib (Alunbrig; AP26113) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2017 View  |  Download
Brexanolone for postpartum depression Brexanolone (SAGE-547; Zulresso) Postnatal depression Mental and Behavioural Health 2019 View  |  Download
Brentuximab vedotin with doxorubicin, dacarbazine and vinblastine for previously untreated late-stage classical Hodgkin lymphoma Brentuximab vedotin (Adcetris; SGN-35) , Dacarbazine (dacarbazine citrate) , Doxorubicin (Livatag; BA-003; Caelyx; Sarcodoxome; SP-1049C; Resmycin; JNS002; doxorubicin hydrochloride) , Vinblastine (vinblastine sulfate) Hodgkin lymphoma Haematological Cancer and Lymphomas 2023 View  |  Download
Brentuximab vedotin in addition to cyclophosphamide, doxorubicin, and prednisolone (CHP) for CD30+ mature T-cell lymphoma Brentuximab vedotin (Adcetris; SGN-35) , CHP Mature T-cell lymphoma Haematological Cancer and Lymphomas 2018 View  |  Download
Brentuximab vedotin (Adcetris) for treatment naive Hodgkin’s Lymphoma Adriamycin , Brentuximab vedotin (Adcetris; SGN-35) , Dacarbazine (dacarbazine citrate) , Vinblastine (vinblastine sulfate) Hodgkin lymphoma Haematological Cancer and Lymphomas 2017 View  |  Download
BPX‐501 to improve Immune Recovery and Graft versus Host Disease (GvHD) after Haploidentical Stem Cell Transplant Rivogenlecleucel (BPX-501) Graft versus host disease (GvHD) , Immunodeficiency Immunology 2018 View  |  Download
Botaretigene sparoparvovec for treating X-linked retinitis pigmentosa Botaretigene sparoparvovec Retinitis pigmentosa Ophthalmology 2023 View  |  Download
Bosutinib (Bosulif) for Philadelphia positive chronic myeloid leukaemia – first line Bosutinib (Bosulif; PF-05208763; bosutinib monohydrate) Chronic myeloid leukaemia (CML) Haematological Cancer and Lymphomas 2017 View  |  Download
BMS-986165 for moderate to severe plaque psoriasis Deucravacitinib (BMS-986165) Plaque psoriasis Dermatology 2020 View  |  Download
Blinatumomab (Blincyto) for First Relapsed/Refractory, B-precursor, Acute Lymphoblastic Leukaemia, in Children and Adolescents Blinatumomab (Blincyto) Acute lymphoblastic leukaemia (ALL) Haematological Cancer and Lymphomas 2017 View  |  Download
1 2 88 89 90 91 92 104 105
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications